Log in
NASDAQ:GTH

Genetron Stock Forecast, Price & News

$13.27
+1.04 (+8.50 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$12.23
Now: $13.27
$14.07
50-Day Range
$9.31
MA: $11.20
$12.27
52-Week Range
$9.03
Now: $13.27
$17.71
Volume514,749 shs
Average Volume292,592 shs
Market Capitalization$1.17 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services through laboratory developed tests services, such as HCCscreen, a proprietary assay for the early screening of liver cancer. It also provides in-vitro diagnostics products, including 8-gene Lung Cancer Assay, an IVD assay product based on semiconductor sequencing to detect lung cancer; Genetron 3D biochip reading instrument; IDH1/TERT gene assays for glioma; GENETRON S5, a semiconductor sequencer used in the field of gene detection; and Genetron S2000 that enables gene panel sequencing. In addition, the company develops ctDNA Lung Cancer assay for mutations in the epidermal growth factor receptor gene. It also offers development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies, hospitals, and research institutions worldwide. The company has a partnership agreement with dMed Biopharmaceutical for new drug research and development in the field of oncology. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.14 out of 5 stars


Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GTH
CUSIPN/A
CIKN/A
Phone86 10 5090 7500
Employees697

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.68 million

Profitability

Miscellaneous

Market Cap$1.17 billion
Next Earnings Date6/28/2021 (Estimated)
OptionableNot Optionable
$13.27
+1.04 (+8.50 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GTH News and Ratings via Email

Sign-up to receive the latest news and ratings for GTH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Genetron (NASDAQ:GTH) Frequently Asked Questions

What stocks does MarketBeat like better than Genetron?

Wall Street analysts have given Genetron a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Genetron wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Genetron's next earnings date?

Genetron is scheduled to release its next quarterly earnings announcement on Monday, June 28th 2021.
View our earnings forecast for Genetron
.

How were Genetron's earnings last quarter?

Genetron Holdings Limited (NASDAQ:GTH) posted its earnings results on Monday, November, 9th. The company reported ($0.08) earnings per share for the quarter. The firm earned $16.49 million during the quarter.
View Genetron's earnings history
.

Who are some of Genetron's key competitors?

Who are Genetron's key executives?

Genetron's management team includes the following people:
  • Dr. Wei-Wu He, Co-Founder & Chairman (Age 55)
  • Mr. Sizhen Wang, Co-Founder, CEO & Director (Age 43)
  • Dr. Hai Yan, Co-Founder, Chief Scientific Officer & Director (Age 52)
  • Mr. Evan Ce Xu, Chief Financial Officer (Age 39)
  • Mr. Ying Hong, Chief Operating Officer (Age 48)
  • Dr. Yuchen Jiao M.D., Ph.D., Chief Technology Officer (Age 43)
  • Dr. Yun-Fu Hu Ph.D., Chief Medical Officer (Age 58)

When did Genetron IPO?

(GTH) raised $162 million in an IPO on Friday, June 19th 2020. The company issued 13,000,000 shares at $11.50-$13.50 per share. Credit Suisse and CICC served as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

What is Genetron's stock symbol?

Genetron trades on the NASDAQ under the ticker symbol "GTH."

How do I buy shares of Genetron?

Shares of GTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genetron's stock price today?

One share of GTH stock can currently be purchased for approximately $13.27.

How big of a company is Genetron?

Genetron has a market capitalization of $1.17 billion and generates $45.68 million in revenue each year. Genetron employs 697 workers across the globe.

What is Genetron's official website?

The official website for Genetron is www.genetronhealth.com.

How can I contact Genetron?

Genetron's mailing address is 1-2/F BUILDING 11 ZONE 1 CHANGPING DISTRICT, BEIJING F4, 102206. The company can be reached via phone at 86 10 5090 7500 or via email at [email protected]

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.